Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2017 Apr;31(2):94-101.
doi: 10.1016/j.tmrv.2016.10.002. Epub 2016 Nov 4.

The Impact of Emerging Infectious Diseases on Chinese Blood Safety

Affiliations
Review

The Impact of Emerging Infectious Diseases on Chinese Blood Safety

Miao He et al. Transfus Med Rev. 2017 Apr.

Abstract

Emerging infectious diseases (EIDs) have always been one of the major threats to public health. Although the implementation of mandatory testing for 4 classical transfusion-transmitted infectious-human immunodeficiency virus, hepatitis B virus, hepatitis C virus, and syphilis-has reduced the transfusion risk of these pathogens, the potential threat of various EID agents and their constantly evolving variants to blood safety in China is not fully understood. This review presents 9 representative EID agents that are autochthonous and epidemic nationally or regionally in China. The epidemiologic status and distribution of these EID agents among donors and/or healthy populations are summarized. The potential risks of these EID agents to blood safety are discussed. The review also explores strategies to strengthen hemovigilance systems and studies to further evaluate the impact of EID agents on blood safety.

Keywords: Chinese blood safety; Emerging infectious diseases; Transfusion-transmitted infectious.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
The distribution of 6 major regional EID agents in China.
Fig. 2
Fig. 2
The distribution and potential prevalence of EID agents in blood donors in China.

Similar articles

Cited by

References

    1. Sabino E.C., Lee T.H., Montalvo L., Nguyen M.L., Leiby D.A., Carrick D.M. Antibody levels correlate with detection of Trypanosoma cruzi DNA by sensitive polymerase chain reaction assays in seropositive blood donors and possible resolution of infection over time. Transfusion. 2013;53:1257–1265. - PMC - PubMed
    1. Benjamin R.J., Stramer S.L., Leiby D.A., Dodd R.Y., Fearon M., Castro E. Trypanosoma cruzi infection in North America and Spain: evidence in support of transfusion transmission. Transfusion. 2012;52:1913–1921. [quiz 2] - PubMed
    1. Leiby D.A., Herron R.M., Garratty G., Herwaldt B.L. Trypanosoma cruzi parasitemia in US blood donors with serologic evidence of infection. J Infect Dis. 2008;198:609–613. - PubMed
    1. Gubernot D.M., Lucey C.T., Lee K.C., Conley G.B., Holness L.G., Wise R.P. Babesia infection through blood transfusions: reports received by the US Food and Drug Administration, 1997-2007. Clin Infect Dis. 2009;48:25–30. - PubMed
    1. Leiby D.A., Johnson S.T., Won K.Y., Nace E.K., Slemenda S.B., Pieniazek N.J. A longitudinal study of Babesia microti infection in seropositive blood donors. Transfusion. 2014;54:2217–2225. - PMC - PubMed

Publication types

MeSH terms